FA
MRK icon

Fiducient Advisors’s Merck MRK Stock Holding History

Fiducient Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Sell
1,872
-1,927
-51% -$222K 0.03% 128
2025
Q4 		$403K Hold
3,799
– – 0.05% 123
2025
Q3 		$322K Buy
3,799
+551
+17% +$45.4K 0.04% 120
2025
Q2 		$260K Sell
3,248
-1,907
-37% -$152K 0.03% 133
2025
Q1 		$465K Buy
5,155
+1,922
+59% +$179K 0.06% 97
2024
Q4 		$324K Sell
3,233
-207
-6% -$21.3K 0.04% 119
2024
Q3 		$393K Buy
3,440
+157
+5% +$18.7K 0.05% 103
2024
Q2 		$409K Buy
3,283
+996
+44% +$128K 0.06% 96
2024
Q1 		$304K Sell
2,287
-2,229
-49% -$275K 0.06% 102
2023
Q4 		$496K Buy
4,516
+1,556
+53% +$162K 0.09% 75
2023
Q3 		$307K Buy
+2,960
New +$319K 0.02% 90

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fiducient Advisors's MRK Position: Q1 2026 in Review

Fiducient Advisors reduced its Merck (MRK) stake by 51% in Q1 2026, selling an estimated $222K and leaving 1,872 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #128.

Fiducient Advisors first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. The position peaked at $496K in Q4 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fiducient Advisors held 1,872 shares of Merck worth $227K as of Q1 2026.
  • Fiducient Advisors sold 1,927 Merck shares in Q1 2026, an estimated $222K.
  • Merck made up 0.03% of Fiducient Advisors's portfolio in Q1 2026, its #128 holding.
  • Fiducient Advisors first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • Fiducient Advisors's Merck position peaked at $496K in Q4 2023.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fiducient Advisors's 13F filing for Q1 2026, filed 11 May 2026.